On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest findings and with his cancer patients, shared their challenging experiences during this pandemic. Go to article Click Here
Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, we analyzed responses to mRNA vaccination against COVID-19 among these patients... Go to article Click Here
New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative LOS ANGELES, Nov. 11, 2020 /PRNewswire/ -- Berenson Cancer Center, a world class multiple myeloma cancer research, diagnostic and treatment center has completed an...
Survival and treatments are improving for this type of blood cancer You don't expect to break a rib while doing light housekeeping. Similarly, you wouldn't think your worsening back pain might be caused by a type of blood cancer. However, these are among classic...
Interview with Debra Berenson, myeloma patient advocate, wife of myeloma expert Dr. James Berenson, and author of the book, I HAVE WHAT? Debra has collected stories, insights, and tools for and from patients and their families with myeloma and related diseases. The...
What: Myeloma is a disease in your bone marrow. Inside your bone marrow are the cells that make your blood, your red cells, your white cells, and your platelets. This plays a key role in maintaining the strength of the bone. Why: There have been several recent...
Tommy, who has been Dr. Berenson’s able assistant for many years, has a passion for athletics and training. In July 2013, he started Team IMBCR at a time when he was also participating in several marathons, half-marathons and trail running and half iron distance...
Original Article Writen by: Robert Carlson - Oncology Times NEW YORK—Treatment regimens for relapsed/refractory multiple myeloma have become plentiful in the past few years, with a panoply of options. Consequently, “the old rules no longer apply,” says James Berenson,...
In response to NBC News Special Correspondent Tom Brokaw’s announcement that he has been diagnosed with multiple myeloma, a rare blood cancer of malignant cells found in the bone marrow, leading physician Dr. James Berenson is encouraged that Mr. Brokaw is receiving...
Dr. Berenson will be the featured Myeloma Cure Talk Panel member on this November 29th, 2012 @ 6:00 PM EST broadcast. You can sign up for the broadcast here. The discussion will cover Dr. Berenson's multiple myeloma treatment philosophy and preferred treatment...
Updates in the Treatment of Multiple Myeloma (PDF)
The Institute for Myeloma & Bone Cancer Research (IMBCR) is pleased to announce the dedication of a newly designed artwork for IMBCR. Artist, Ted Kirby, named the artwork “Determination”, in honor of all those who are determined to cure Multiple Myeloma. Please...
Dr. James Berenson helps patients understand new FDA recommendations regarding the use of lenalidomide (Revlimid) and a study from Sweden regarding increased risk of blot clots for myeloma patients. Dr. Berenson also previews the topics that he believes will be...
Oncotherapeutics, an oncology specific Contract Research Organization (CRO) specializing in the oversight and management of clinical trails for cnacer, will present final results from a multicenter clinical trial at the American Society of Hematology Annual Meeting in...
The results of this landmark study should be welcomed news to cancer patients across the world suffering from the debilitating effects of painful vertebral compression fractures,” said Dr. James Berenson, the study's first author and Medical and Scientific Director of...
